経皮的冠動脈形成術(PCI)の世界市場分析・予測

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 11
2.1 Catalyst 11
2.2 Related Reports 12
3 Market Access 13
3.1 Reimbursement Trends 13
3.1.1 North America 13
3.1.2 Europe 16
3.1.3 Asia-Pacific 17
3.1.4 South America 20
3.1.5 Middle East and Africa 21
3.2 Mergers and Acquisitions/Key Partnerships 23
4 Unmet Needs and Market Opportunity Analysis 24
4.1 Improving Clinical Outcomes in Complex Coronary Indications 24
4.1.1 Bifurcation Lesions 25
4.1.2 Chronic Total Occlusions 26
4.1.3 Heavily Calcified Lesions 27
4.1.4 Unprotected Left Main Coronary Artery Lesions 27
4.1.5 Acute Myocardial Infarction 28
4.1.6 Saphenous Vein Grafts 28
4.1.7 Small Vessel Lesions 29
4.2 Minimizing Late Stent Thrombosis Incidence 29
4.3 Procedure Optimization 29
4.4 Reducing Repeat Revascularization Rates 30
5 Competitive Assessment 32
5.1 Market Share Analysis 32
5.2 Key Companies and Product Profiles 34
5.2.1 Abbott Vascular 34
5.2.2 B. Braun 37
5.2.3 Biosensors International 41
5.2.4 Biotronik 45
5.2.5 Boston Scientific 49
5.2.6 Medtronic 53
5.2.7 Terumo 56
5.2.8 Other Players 58
5.3 Pipeline Products Assessment 61
5.4 Clinical Trials Assessment 64
6 Market Outlook 65
6.1 Procedure Trends 65
6.2 Global Market Drivers and Barriers 66
6.2.1 Driver: Rising Disease Prevalence 66
6.2.2 Driver: Launch of Bioabsorbable Stents on a Global Scale 67
6.2.3 Driver: Reducing Need for Antiplatelet Therapy 67
6.2.4 Barrier: Risk of Perioperative Adverse Cardiac Events Post-Stenting 68
6.2.5 Barrier: Post-ProceduraI Complications of Drug-Eluting Stenting 68
6.2.6 Barrier: Concerns Regarding Overstenting 69
6.3 Market Outlooks by Segment 70
6.3.1 Coronary Stents 70
6.3.2 Percutaneous Transluminal Coronary Angioplasty Balloons 72
6.3.3 Percutaneous Transluminal Angioplasty Drug-Eluting Balloons 74
6.4 Market Outlooks by Geography 74
6.4.1 Global Overview 74
6.4.2 North America 76
6.4.3 Europe 77
6.4.4 Asia-Pacific 78
6.4.5 South America 80
6.4.6 Middle East and Africa 81
7 Appendix 82
7.1 Bibliography 82
7.2 Abbreviations 92
7.3 Methodology 95
7.3.1 Overview 95
7.3.2 Coverage 95
7.3.3 Secondary Research 95
7.4 Forecasting Methodology 96
7.5 Primary Research Summary 96
7.6 About the Authors 98
7.6.1 Premdharan Meyyan, Cardiovascular Analyst, Medical Devices 98
7.6.2 Linda Tian, Msc, Managing Analyst, Medical Devices 98
7.6.3 Tyler Fletcher, Global Head of Medical Devices 99
7.7 About GlobalData 100
7.8 Disclaimer 100